NasdaqCM - Nasdaq Real Time Price USD

Leap Therapeutics, Inc. (LPTX)

0.3614
-0.0188
(-4.94%)
At close: May 21 at 4:00:01 PM EDT
0.3754
+0.01
+(3.87%)
After hours: May 21 at 7:39:34 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
1,500
Operating Expense
71,340
70,057
85,940
54,712
41,700
Operating Income
-71,340
-70,057
-85,940
-54,712
-40,200
Net Non Operating Interest Income Expense
2,785
3,129
4,027
871
-32
Other Income Expense
-30
-42
499
-608
-379
Pretax Income
-68,585
-66,970
-81,414
-54,449
-40,611
Tax Provision
--
585
0
147
-24
Net Income Common Stockholders
-69,404
-67,789
-81,414
-54,596
-40,587
Diluted NI Available to Com Stockholders
-69,404
-67,789
-81,414
-54,596
-40,587
Basic EPS
-1.67
-1.81
-3.98
-4.80
-4.70
Diluted EPS
-1.67
-1.81
-3.98
-4.80
-4.70
Basic Average Shares
41,114.3760
37,550.6770
20,445.1090
11,323.9090
8,582.5280
Diluted Average Shares
41,114.3760
37,550.6770
20,445.1090
11,323.9090
8,582.5280
Total Operating Income as Reported
-71,149
-70,057
-87,041
-56,763
-41,426
Total Expenses
71,340
70,057
85,940
54,712
41,700
Net Income from Continuing & Discontinued Operation
-69,170
-67,555
-81,414
-54,596
-40,587
Normalized Income
-69,140
-67,521.8200
-81,413
-53,988
-40,208
Interest Income
2,791
3,129
4,027
925
9
Interest Expense
--
--
0
54
41
Net Interest Income
2,785
3,129
4,027
871
-32
EBIT
-71,666
-70,057
-85,940
-54,395
-40,570
EBITDA
-71,666
-70,052
-85,925
-54,379
-40,541
Reconciled Depreciation
0
5
15
16
29
Net Income from Continuing Operation Net Minority Interest
-69,170
-67,555
-81,414
-54,596
-40,587
Total Unusual Items Excluding Goodwill
-30
-42
-1
-608
-379
Total Unusual Items
-30
-42
-1
-608
-379
Normalized EBITDA
-71,636
-70,010
-85,924
-53,771
-40,162
Tax Rate for Calcs
0
0.0002
0
0
0
Tax Effect of Unusual Items
0
-8.8200
0
0
0
12/31/2021 - 1/25/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GLMD Galmed Pharmaceuticals Ltd.
1.3700
0.00%
 
MBIO Mustang Bio, Inc.
1.1900
-4.03%
 
HOTH Hoth Therapeutics, Inc.
0.8350
-1.28%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5500
+1.93%
 
CRVS Corvus Pharmaceuticals, Inc.
3.6300
-1.36%
 
MNPR Monopar Therapeutics Inc.
35.56
-3.63%
 
ADAP Adaptimmune Therapeutics plc
0.2750
-4.28%
 
MREO Mereo BioPharma Group plc
2.2400
-2.61%
 
RLMD Relmada Therapeutics, Inc.
0.5193
-13.02%
 
MRSN Mersana Therapeutics, Inc.
0.3533
-9.41%